lamictal
glaxosmithkline trading services limited - lamotriginas - kramtomosios ar disperguojamosios tabletės - 2 mg; 200 mg; 100 mg; 50 mg; 25 mg; 5 mg - lamotrigine
fentanilis sanitas
pharmaswiss Česká republika s.r.o. - fentanilis - injekcinis tirpalas - 50 µg/ml - fentanyl
dolforin
gedeon richter plc - fentanilis - transderminis pleistras - 50 µg/val; 75 µg/val; 100 µg/val.; 25 µg/val - fentanyl
kanilad
medochemie ltd. - lakozamidas - plėvele dengtos tabletės - 200 mg; 150 mg; 100 mg; 50 mg - lacosamide
dzuveo
laboratoire aguettant - sufentanilas citratas - skausmas - anestezijos - dzuveo is indicated for the management of acute moderate to severe pain in adult patients.
lacosamide ucb
ucb pharma s.a. - lakozamidas - epilepsijos, dalinis - antiepileptics, - lacosamide ucb yra nurodyta kaip monotherapy ir adjunctive terapijos gydymo dalies pasireiškė traukuliai su ar be antrinės apibendrinimo suaugusiems, paaugliams ir vaikams nuo 4 metų amžiaus, su epilepsija.
sontilen
medochemie ltd. - sufentanilis - injekcinis ar infuzinis tirpalas - 5 µg/ml - sufentanil
sontilen
medochemie ltd. - sufentanilis - injekcinis ar infuzinis tirpalas - 50 µg/ml - sufentanil
lacosamide fresenius kabi
fresenius kabi polska sp.z.o.o. - lakozamidas - infuzinis tirpalas - 10 mg/ml - lacosamide
lacosamide adroiq
extrovis eu ltd. - lakozamidas - epilepsija - antiepileptics, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.